Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy
Open Access
- 1 January 2012
- journal article
- Published by Springer Nature in EJNMMI Research
- Vol. 2 (1) , 20
Abstract
Anemia is usually not taken into account in internal radiotherapy. We investigated whether the hemoglobin (Hb) level could have an impact on the tumor response, as observed in external beam radiotherapy (EBRT).Keywords
This publication has 42 references indexed in Scilit:
- Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary ResultsJournal of Nuclear Medicine, 2012
- Hypofractionation Results in Reduced Tumor Cell Kill Compared to Conventional Fractionation for Tumors With Regions of HypoxiaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Yttrium-90-labeled microsphere tracking during liver selective internal radiotherapy by bremsstrahlung pinhole SPECT: feasibility study and evaluation in an abdominal phantomEJNMMI Research, 2011
- Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic ConsiderationsJournal of Nuclear Medicine, 2010
- Serum Hemoglobin Levels Predict Response to Strontium-89 and Rhenium-186-HEDP Radionuclide Treatment for Painful Osseous Metastases in Prostate CancerUrologia Internationalis, 2006
- Hypoxia in head and neck cancer: How much, how important?Head & Neck, 2005
- The impact of anaemia on outcome in cancerClinical and Laboratory Haematology, 2005
- The hypoxic tumor microenvironment and gene expressionSeminars in Radiation Oncology, 2004
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- The linear-quadratic formula and progress in fractionated radiotherapyBritish Journal of Radiology, 1989